Pharmacy Report Archives - Page 24 of 153 - Becker's Hospital Review

US might restrict China-made drugs | FDA cracks down on drug ads | CVS settles with Okla. for $32M | 12 fastest-growing healthcare jobs | GLP-1s reduce fracture risks: Study

September 10, 2025 1. Trump administration eyes crackdown on Chinese drugs Full story 2. HHS, FDA to crack down on drug ads Full story 3. Hartford HealthCare is using AI to optimize nurse shifts & retention. Learn how — live…

Top policy issues for pharmacy leaders | AHA urges federal probe of 340B rebates | Amazon Pharmacy expands to Texas | Allina closes hospital infusion center | GLP-1s added to WHO's essential medicine list

September 9, 2025 1. 3 policy issues on pharmacy leaders' radar Full story 2. AHA urges federal probe of 340B rebate models: 5 notes Full story 3. How NewYork-Presbyterian is aligning metrics + workflows across infusion centers: here. 4. Amazon…

Trump edits pharma tariffs: 5 notes | Are prescriptions fueling rising fall deaths? | 3 GLP-1 updates | CVS sued over Zepbound change | UVA Health hits pharmacy milestone

September 8, 2025 1. Trump eyes easing tariffs on pharmaceuticals: 5 notes Full story 2. Wegovy gains new approval: 3 GLP-1 updates Full story 3. Margins are under pressure. Innovation is on the rise. Discover how the nation's top CPOs…

FDA warns Amneal of 'significant violations' | Common nasal spray lowers COVID risk in study | 10 systems seeking pharmacy leaders | Hospital drug costs soar | Managers stretched thin

September 4, 2025 1. FDA slams Amneal for 'significant violations' in warning letter Full story 2. Common nasal spray may lower COVID-19 risk: Study Full story 3. Prior auth bottlenecks hurt access. Fix handoffs with automation here. 4. Repurposed drugs…

Real-time drug pricing rule to take effect | Cigna invests $3.5B in specialty pharma co. | Weekly Alzheimer's drug approved | COVID activity rises amid vaccine uncertainty | Federal PBM probe widens

September 3, 2025 1. Real-time drug pricing access rule to take effect Full story 2. Trump demands COVID 'drug' data from pharmaceutical companies Full story 3. How Prisma Health is delivering upfront cost clarity for patients — here. 4. FDA…

CVS, Walgreens limit COVID shot access | Sanford to buy 60 pharmacies | 15 best, worst cities to retire | Walgreens splits into 5 companies | NY system CEO to step down

September 2, 2025 1. CVS, Walgreens scale back COVID-19 vaccine availability Full story 2. Sanford Health to acquire pharmacy, retail store with 60 locations Full story 3. Prior auth bottlenecks hurt access. Fix handoffs with automation here. 4. Walgreens goes…

AHA slams 340B rebate pilot | Walgreens names CEO as it goes private | 10 systems seeking pharmacy leaders | Top 15 exec MBA programs: US News | Big wins for 5 system pharmacies

August 28, 2025 1. AHA rebukes 340B rebate pilot program Full story 2. Walgreens names pharma vet CEO as it goes private Full story 3. Time to therapy matters. Tech-driven tips to streamline prior auth here. 4. The big wins…

5 new drug shortages | Pfizer lays off 100 | GLP-1s & cancer: What to know | Pharma groups challenge ND 340B law | Rising stars: Healthcare leaders under 40

August 27, 2025 1. 5 drugs in shortage Full story 2. GLP-1s and cancer: What to know Full story 3. Reduce prescription abandonment with responsible AI workflows here. 4. Pharma groups sue to block North Dakota 340B law Full story…

Pharmacy in 2026: 5 leaders' strategies | 3 new drugs to watch: Optum | Ind. system CEO exits after 5 months | Most generics sourced overseas | Oral GLP-1 leads to 10% weight loss

August 26, 2025 1. Pharmacy in 2026: How health systems are preparing Full story 2. 3 new drugs to watch: Optum Full story 3. Even de-identified data isn't safe. The hidden AI privacy risk leaders need to know — here.…

FDA suspends chikungunya vaccine | 340B, explained | GLP-1s tied to reduced cancer risk | Amazon Pharmacy seeks CPO | Drug costs squeeze hospital margins

August 25, 2025 1. The 340B program, explained Full story 2. FDA suspends chikungunya vaccine over side effects Full story 3. Mercy notches $21.2M in cost savings with automation. Learn how here. 4. GLP-1 use linked to reduced cancer risk:…